Universal Health Services Inc
$ 145.17
1.72%
05 Jun - close price
- Market Cap 8,639,748,000 USD
- Current Price $ 145.17
- High / Low $ 148.58 / 144.00
- Stock P/E 5.96
- Book Value 123.31
- EPS 23.95
- Next Earning Report 2026-07-27
- Dividend Per Share $0.80
- Dividend Yield 0.55 %
- Next Dividend Date 2026-06-18
- ROA 0.08 %
- ROE 0.21 %
- 52 Week High 245.89
- 52 Week Low 140.76
About
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Analyst Target Price
$218.12
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-04-27 | 2026-02-25 | 2025-10-27 | 2025-07-28 | 2025-04-28 | 2025-02-26 | 2024-10-24 | 2024-07-24 | 2024-04-24 | 2024-02-27 | 2023-10-25 | 2023-07-25 |
| Reported EPS | 5.62 | 5.88 | 5.69 | 5.35 | 4.84 | 4.92 | 3.71 | 4.31 | 3.7 | 3.13 | 2.55 | 2.53 |
| Estimated EPS | 5.46 | 5.88 | 4.95 | 4.96 | 4.36 | 4.1753 | 3.7 | 3.32 | 3.14 | 2.88 | 2.36 | 2.42 |
| Surprise | 0.16 | 0 | 0.74 | 0.39 | 0.48 | 0.7447 | 0.01 | 0.99 | 0.56 | 0.25 | 0.19 | 0.11 |
| Surprise Percentage | 2.9304% | 0% | 14.9495% | 7.8629% | 11.0092% | 17.8358% | 0.2703% | 29.8193% | 17.8344% | 8.6806% | 8.0508% | 4.5455% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-07-27 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 5.66 |
| Currency | USD |
Previous Dividend Records
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Payment Date | 2026-03-16 | 2025-12-15 | 2025-09-16 | 2025-06-16 | 2025-03-17 | 2024-12-17 | 2024-09-17 | 2024-06-17 | 2024-03-15 | 2023-12-15 |
| Amount | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 | $0.2 |
Next Dividend Records
| Dividend per share (year): | $0.80 |
| Dividend Yield | 0.55% |
| Next Dividend Date | 2026-06-18 |
| Ex-Dividend Date | 2026-06-08 |
Recent News: UHS
2026-06-05 05:37:46
This article analyzes an investment comparison between Nutex Health (NUTX) and HCA Healthcare (HCA), suggesting NUTX as the superior choice due to its higher revenue growth, better profitability, and lower valuation. While acknowledging the inherent risks in stock investment, the analysis provides detailed financial metrics and historical performance data to support its recommendation for NUTX. It also advocates for a portfolio approach over individual stock picking to mitigate risk.
2026-06-04 17:18:00
Universal Health Services Inc. Cl B (UHS) stock fell 2.23% on Thursday, closing at $142.72. This performance lagged behind the broader market, as the S&P 500 Index and Dow Jones Industrial Average both saw gains. The stock is currently 42.06% below its 52-week high reached in November.
2026-06-03 09:10:42
Ardent Health has appointed Dave Caspers, previously Chief Operating Officer, as its new President and Chief Executive Officer, effective immediately. He succeeds Marty Bonick. Caspers will also join the company's Board of Directors. The company reaffirmed its full-year 2026 Adjusted EBITDA guidance despite recent volume softness.
2026-06-02 23:40:20
Encompass Health (EHC) plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, West Virginia, replacing an older facility and expanding its regional footprint. This expansion aligns with the company's growth strategy, which is supported by raised 2026 revenue guidance and new hospitals planned in other states. While these developments underpin a positive growth narrative, investors should consider the increased capital commitments and potential risks associated with labor costs, capital intensity, and government reimbursement.
2026-06-02 23:31:15
This article announces that Dave Caspers, an insider at Ardent Health, has been appointed as the new CEO of the company. No further details are available in the provided content.
2026-06-02 18:37:40
HCA Healthcare is presented as a compelling investment due to its strong annualized EPS growth of 19.9% over five years, outpacing peers and revenue growth. The company, a market leader with significant economies of scale, delivered Q1 CY2026 results that met revenue and adjusted EPS expectations. Despite a slight miss on adjusted EBITDA, the report suggests HCA is attractively priced and a "rock-solid business" with a consensus one-year price target indicating a significant upside.
